home.social

#cancerdiagnostics — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #cancerdiagnostics, aggregated by home.social.

fetched live
  1. 🔬 The Histology and Cytology Market is growing rapidly.

    📈 Market size is expected to reach USD 21,763.81 Million by 2035, growing at a 7.8% CAGR.

    Growth is driven by rising cancer diagnosis rates, increasing laboratory testing demand, and advances in tissue analysis technology.

    📥 Sample Report:
    researchreportsworld.com/enqui

    #Histology #Cytology #CancerDiagnostics #Pathology #HealthTech #LifeSciences

  2. 🐶🩸 Could a routine blood sample unlock earlier detection of breast cancer in dogs?

    🔗 DNA Methylation in Blood Samples from Malignant Mammary Tumors of Companion Dogs: A Pilot Study. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0104

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #VeterinaryMedicine #VeterinaryOncology #BreastCancerResearch #CanineCancer #Epigenetics #VeterinaryScience #OncologyResearch #MolecularBiology #CancerDiagnostics

  3. 🐶🩸 Could a routine blood sample unlock earlier detection of breast cancer in dogs?

    🔗 DNA Methylation in Blood Samples from Malignant Mammary Tumors of Companion Dogs: A Pilot Study. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0104

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #VeterinaryMedicine #VeterinaryOncology #BreastCancerResearch #CanineCancer #Epigenetics #VeterinaryScience #OncologyResearch #MolecularBiology #CancerDiagnostics

  4. 🐶🩸 Could a routine blood sample unlock earlier detection of breast cancer in dogs?

    🔗 DNA Methylation in Blood Samples from Malignant Mammary Tumors of Companion Dogs: A Pilot Study. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0104

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #VeterinaryMedicine #VeterinaryOncology #BreastCancerResearch #CanineCancer #Epigenetics #VeterinaryScience #OncologyResearch #MolecularBiology #CancerDiagnostics

  5. 🐶🩸 Could a routine blood sample unlock earlier detection of breast cancer in dogs?

    🔗 DNA Methylation in Blood Samples from Malignant Mammary Tumors of Companion Dogs: A Pilot Study. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0104

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #VeterinaryMedicine #VeterinaryOncology #BreastCancerResearch #CanineCancer #Epigenetics #VeterinaryScience #OncologyResearch #MolecularBiology #CancerDiagnostics

  6. 🐶🩸 Could a routine blood sample unlock earlier detection of breast cancer in dogs?

    🔗 DNA Methylation in Blood Samples from Malignant Mammary Tumors of Companion Dogs: A Pilot Study. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0104

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #VeterinaryMedicine #VeterinaryOncology #BreastCancerResearch #CanineCancer #Epigenetics #VeterinaryScience #OncologyResearch #MolecularBiology #CancerDiagnostics

  7. 🩸 Liquid Biopsy - Apr 2026

    • ctDNA clearance predicts treatment efficacy in large B-cell lymphoma
    • ecDNA identified as key driver of therapy resistance in prostate cancer
    • Platelets emerging as biomarker for ovarian cancer detection
    • KIM-1 levels correlate with treatment response in renal cell carcinoma

    pir.sh/32p176rgwv

    #LiquidBiopsy #CancerDiagnostics

  8. 🔬 Digital pathology is no longer the future—it’s transforming diagnostics today.
    AI, molecular biology, and cloud platforms are reshaping how pathologists work. From 99% diagnostic accuracy to faster workflows and real‑time global collaboration, digital pathology is changing patient care and precision medicine.

    Read more 👉 blog.banishcancer.org/digital-

    #DigitalPathology #Oncology #AIinHealthcare #PrecisionMedicine #CancerDiagnostics #BanishCancer

  9. 🔬 Digital pathology is no longer the future—it’s transforming diagnostics today.
    AI, molecular biology, and cloud platforms are reshaping how pathologists work. From 99% diagnostic accuracy to faster workflows and real‑time global collaboration, digital pathology is changing patient care and precision medicine.

    Read more 👉 blog.banishcancer.org/digital-

    #DigitalPathology #Oncology #AIinHealthcare #PrecisionMedicine #CancerDiagnostics #BanishCancer

  10. 🔬 Digital pathology is no longer the future—it’s transforming diagnostics today.
    AI, molecular biology, and cloud platforms are reshaping how pathologists work. From 99% diagnostic accuracy to faster workflows and real‑time global collaboration, digital pathology is changing patient care and precision medicine.

    Read more 👉 blog.banishcancer.org/digital-

    #DigitalPathology #Oncology #AIinHealthcare #PrecisionMedicine #CancerDiagnostics #BanishCancer

  11. 💉 Could buffer design revolutionize how we detect circulating tumor cells (CTCs) in cancer patients?

    🔗 Design of buffer property for the new enrichment method of circulating tumor cell based on immunomagnetic-negative separation. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2024.11

    📚 CSBJ Nanoscience & Advanced Materials: csbj.org/nano

    #CancerResearch #LiquidBiopsy #Oncology #Immunotherapy #PrecisionMedicine #CancerDiagnostics #Biomarkers #CancerDetection

  12. 💉 Could buffer design revolutionize how we detect circulating tumor cells (CTCs) in cancer patients?

    🔗 Design of buffer property for the new enrichment method of circulating tumor cell based on immunomagnetic-negative separation. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2024.11

    📚 CSBJ Nanoscience & Advanced Materials: csbj.org/nano

    #CancerResearch #LiquidBiopsy #Oncology #Immunotherapy #PrecisionMedicine #CancerDiagnostics #Biomarkers #CancerDetection

  13. 💉 Could buffer design revolutionize how we detect circulating tumor cells (CTCs) in cancer patients?

    🔗 Design of buffer property for the new enrichment method of circulating tumor cell based on immunomagnetic-negative separation. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2024.11

    📚 CSBJ Nanoscience & Advanced Materials: csbj.org/nano

    #CancerResearch #LiquidBiopsy #Oncology #Immunotherapy #PrecisionMedicine #CancerDiagnostics #Biomarkers #CancerDetection

  14. 💉 Could buffer design revolutionize how we detect circulating tumor cells (CTCs) in cancer patients?

    🔗 Design of buffer property for the new enrichment method of circulating tumor cell based on immunomagnetic-negative separation. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2024.11

    📚 CSBJ Nanoscience & Advanced Materials: csbj.org/nano

    #CancerResearch #LiquidBiopsy #Oncology #Immunotherapy #PrecisionMedicine #CancerDiagnostics #Biomarkers #CancerDetection

  15. Pearsanta receives DoD invitation for groundbreaking ovarian cancer diagnostic research, potentially revolutionizing early detection methods with innovative blood-based test #MedicalResearch #CancerDiagnostics

  16. Pearsanta receives DoD invitation for groundbreaking ovarian cancer diagnostic research, potentially revolutionizing early detection methods with innovative blood-based test #MedicalResearch #CancerDiagnostics

  17. Pearsanta receives DoD invitation for groundbreaking ovarian cancer diagnostic research, potentially revolutionizing early detection methods with innovative blood-based test #MedicalResearch #CancerDiagnostics

  18. Congratulations to Aiina Robotics on winning first place at this year’s #TUMIDEAward! The teams from ReduCO2 and Bioexotec won 2nd and 3rd place, respectively: go.tum.de/240156 🎉

    #ConstructionTech #CO2Reduction #CancerDiagnostics
    #startups

    📷A. Heddergott

  19. Congratulations to Aiina Robotics on winning first place at this year’s #TUMIDEAward! The teams from ReduCO2 and Bioexotec won 2nd and 3rd place, respectively: go.tum.de/240156 🎉

    #ConstructionTech #CO2Reduction #CancerDiagnostics
    #startups

    📷A. Heddergott

  20. Congratulations to Aiina Robotics on winning first place at this year’s #TUMIDEAward! The teams from ReduCO2 and Bioexotec won 2nd and 3rd place, respectively: go.tum.de/240156 🎉

    #ConstructionTech #CO2Reduction #CancerDiagnostics
    #startups

    📷A. Heddergott

  21. Congratulations to Aiina Robotics on winning first place at this year’s #TUMIDEAward! The teams from ReduCO2 and Bioexotec won 2nd and 3rd place, respectively: go.tum.de/240156 🎉

    #ConstructionTech #CO2Reduction #CancerDiagnostics
    #startups

    📷A. Heddergott

  22. Congratulations to Aiina Robotics on winning first place at this year’s #TUMIDEAward! The teams from ReduCO2 and Bioexotec won 2nd and 3rd place, respectively: go.tum.de/240156 🎉

    #ConstructionTech #CO2Reduction #CancerDiagnostics
    #startups

    📷A. Heddergott

  23. RT @[email protected]

    🩸Liquid biopsies: the future of cancer early detection

    Read our recent review describing how a spectroscopic approach may pave the way for more efficient cancer diagnostics.

    rdcu.be/c6CcI

    #CancerDiagnostics #LiquidBiopsy #Cancer

  24. RT @[email protected]

    🩸Liquid biopsies: the future of cancer early detection

    Read our recent review describing how a spectroscopic approach may pave the way for more efficient cancer diagnostics.

    rdcu.be/c6CcI

    #CancerDiagnostics #LiquidBiopsy #Cancer

  25. RT @[email protected]

    🩸Liquid biopsies: the future of cancer early detection

    Read our recent review describing how a spectroscopic approach may pave the way for more efficient cancer diagnostics.

    rdcu.be/c6CcI

    #CancerDiagnostics #LiquidBiopsy #Cancer

  26. RT @[email protected]

    🩸Liquid biopsies: the future of cancer early detection

    Read our recent review describing how a spectroscopic approach may pave the way for more efficient cancer diagnostics.

    rdcu.be/c6CcI

    #CancerDiagnostics #LiquidBiopsy #Cancer